Reversal of thiamine deficiency-induced neurodegeneration

Journal of Neuropathology and Experimental Neurology

Volumn 62, Issue 2, 2003, Pages 195-207

  Ke, Zun Ji ^a   DeGiorgio, Lorraine A ^a   Volpe, Bruce T ^a   Gibson, Gary E ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

F4 80; Fluoro Jade; Hemeoxygenase 1; Microglia; NeuN; Neurodegeneration; Thiamine

Indexed keywords

HEME OXYGENASE 1; NEU DIFFERENTIATION FACTOR;

AEROBIC METABOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEGENERATIVE DISEASE; ENDOTHELIUM CELL; MICROGLIA; MOLECULAR BIOLOGY; MOUSE; NERVE CELL NECROSIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; THIAMINE DEFICIENCY;

EID: 0037317426     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnen/62.2.195     Document Type: Article

References (42)

1. Gibson GE, Park LC, Zhang H, Sorbi S, Calingasan NY. Oxidative stress and a key metabolic enzyme in Alzheimer brains, cultured cells, and an animal model of chronic oxidative deficits. Ann N Y Acad Sci 1999;893:79-94
2. Gibson GE, Sheu KF, Blass JP. Abnormalities of mitochondrial enzymes in Alzheimer disease. J Neural Transm 1998;105:855-70
3. Gibson GE, Zhang H, Sheu KF. et al. Alpha-ketoglutarate dehydrogenase in Alzheimer brains bearing the APP670/671 mutation. Ann Neurol 1998;44:676-81
4. Blass JP, Sheu RK, Gibson GE. Inherent abnormalities in energy metabolism in Alzheimer disease. Interaction with cerebrovascular compromise. Ann N Y Acad Sci 2000;903:204-21
5. Gibson GE, Park LC, Sheu KF, Blass JP, Calingasan NY. The alpha-ketoglutarate dehydrogenase complex in neurodegeneration. Neurochem Int 2000;36:97-112
6. Gibson GE, Kingsbery AE, Xu H, et al. Deficit in a Krebs cycle mitochondrial enzyme in brains from patients with Parkinson's disease. J Neurochem (Supplement) 2001;78:132
7. Bogdanov MB, Andreassen OA, Dedeoglu A, Ferrante RJ, Beal MF. Increased oxidative damage to DNA in a transgenic mouse model of Huntington's disease. J Neurochem 2001;79:1246-49
8. Grunewald T, Beal MF. Bioenergetics in Huntington's disease. Ann N Y Acad Sci 1999;893:203-13
9. Park LC, Albers DS, Xu H, Lindsay JG, Beal MF, Gibson GE. Mitochondrial impairment in the cerebellum of the patients with progressive supranuclear palsy. J Neurosci Res 2001;66:1028-34
10. Lavoie J, Butterworth RF. Reduced activities of thiamine-dependent enzymes in brains of alcoholics in the absence of Wernicke's encephalopathy. Alcohol Clin Exp Res 1995;19:1073-77
11. Heroux M, Butterworth RF. Regional alterations of thiamine phosphate esters and of thiamine diphosphate-dependent enzymes in relation to function in experimental Wernicke's encephalopathy. Neurochem Res 1995;20:87-93
12. Mastrogiacomo F, Kish SJ. Cerebellar alpha-ketoglutarate dehydrogenase activity is reduced in spinocerebellar ataxia type 1. Ann Neurol 1994;35:624-26
13. Calingasan NY, Chun WJ, Park LC, Uchida K, Gibson GE. Oxidative stress is associated with region-specific neuronal death during thiamine deficiency. J Neuropathol Exp Neurol 1999;58:946-58
14. Calingasan NY, Huang PL, Chun HS, Fabian A, Gibson GE. Vascular factors are critical in selective neuronal loss in an animal model of impaired oxidative metabolism. J Neuropathol Exp Neurol 2000;59:207-17
15. Calingasan NY, Gibson GE. Dietary restriction attenuates the neuronal loss, induction of heme oxygenase-1 and blood-brain barrier breakdown induced by impaired oxidative metabolism. Brain Res 2000;885:62-69
16. Franklin KBJ, Paxinos G. The mouse brain in stereotaxic coordinates. San Diego: Academic Press, 1997
17. Lange MS, Johnston MV, Tseng EE, et al. Apoptosis detection in brain using low-magnification dark-field microscopy. Exp Neurol 1999;158:254-60
18. Schmued LC, Hopkins KJ. Fluoro-Jade B: A high affinity fluorescent marker for the localization of neuronal degeneration. Brain Res 2000;874:123-30
19. Saji M, Blau AD, Volpe BT. Prevention of transneuronal degeneration of neurons in the substantia nigra reticulata by ablation of the subthalamic nucleus. Exp Neurol 1996;141:120-29
20. Mullen RJ, Buck CR, Smith AM. NeuN, a neuronal specific nuclear protein in vertebrates. Development 1992;116:201-11
21. Hume DA, Halpin D, Charlton H, Gordon S. The mononuclear phagocyte system of the mouse defined by immunohistochemical localization of antigen F4/80: Macrophages of endocrine organs. Proc Natl Acad Sci U S A 1984;81:4174-77
22. Perry VH, Hume DA, Gordon S. Immunohistochemical localization of macrophages and microglia in the adult and developing mouse brain. Neuroscience 1985;15:313-26
23. Sandau K, Pfeilschifter J, Brune B. Nitrosative and oxidative stress induced heme oxygenase-1 accumulation in rat mesangial cells. Eur J Pharmacol 1998;342:77-84
24. Todd KG, Butterworth RF. Early microglial response in experimental thiamine deficiency: An immunohistochemical analysis. Glia 1999;25:190-98
25. Watanabe I, Kanabe S. Early edematous lesion of pyrithiamine induced acute thiamine deficient encephalopathy in the mouse. J Neuropathol Exp Neurol 1978;37:401-13
26. Calingasan NY, Gibson GE. Vascular endothelium is a site of free radical production and inflammation in areas of neuronal loss in thiamine-deficient brain. Ann N Y Acad Sci 2000;903:353-56
27. Ferguson M, Dalve-endres AM, McRee RC, Langlais PJ. Increased mast cell degranulation within thalamus in early pre-lesion stages of an experimental model of Wernicke's encephalopathy. J Neuropathol Exp Neurol 1999;58:773-83
28. Park LC, Zhang H, Gibson GE. Co-culture with astrocytes or microglia protects metabolically impaired neurons. Mech Ageing Dev 2001;123:21-27
29. Langlais PJ, Zhang SX. Cortical and subcortical white matter damage without Wernicke's encephalopathy after recovery from thiamine deficiency in the rat. Alcohol Clin Exp Res 1997;21:434-43
30. Zhang SX, Weilersbacher GS, Henderson SW, Corso T, Olney JW, Langlais PJ. Excitotoxic cytopathology, progression, and reversibility of thiamine deficiency-induced diencephalic lesions. J Neuropathol Exp Neurol 1995;54:255-67
31. Schmued LC, Albertson C, Slikker W Jr. Fluoro-Jade: A novel fluorochrome for the sensitive and reliable histochemical localization of neuronal degeneration. Brain Res 1997;751:37-46
32. Schmued LC, Hopkins KJ. Fluoro-Jade B: A high affinity fluorescent marker for the localization of neuronal degeneration. Brain Res 2000;874:123-30
33. Ye X, Carp RI, Schmued LC, Scallet AC. Fluoro-Jade and silver methods: Application to the neuropathology of scrapie, a transmissible spongiform encephalopathy. Brain Res Brain Res Protoc 2001;8:104-12
34. Butler TL, Kassed CA, Sanberg PR, Willing AE, Pennypacker KR. Neurodegeneration in the rat hippocampus and striatum after middle cerebral artery occlusion. Brain Res 2002;929:252-60
35. DeGiorgio LA, Dibinis C, Milner TA, Saji M, Volpe BT. Histological and temporal characteristics of nigral transneuronal degeneration after striatal injury. Brain Res 1998;795:1-9
36. Park LC, Calingasan NY, Uchida K, Zhang H, Gibson GE. Metabolic impairment elicits brain cell type-selective changes in oxidative stress and cell death in culture. J Neurochem 2000;74:114-24
37. Hazell AS, McGahan L, Tetzlaff W, et al. Immediate-early gene expression in the brain of the thiamine-deficient rat. J Mol Neurosci 1998;10:1-15
38. Matsushima K, MacManus JP, Hakim AM. Apoptosis is restricted to the thalamus in thiamine-deficient rats. Neuroreport 1997;8:867-70
39. Collins GH. Glial cell changes in the brain stem of thiamine-deficient rats. Am J Pathol 1967;50:791-814
40. Bidmon HJ, Emde B, Oermann E, Kubitz R, Witte OW, Zilles K. Heme oxygenase-1 (HSP-32) and heme oxygenase-2 induction in neurons and glial cells of cerebral regions and its relation to iron accumulation after focal cortical photothrombosis. Exp Neurol 2001;168:1-22
41. Garnier P, Demougeot C, Bertrand N, et al. Stress response to hypoxia in gerbil brain: HO-1 and Mn SOD expression and glial activation. Brain Res 2001;893:301-9
42. Lee TS, Chau LY. Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in mice. Nat Med 2002;8:240-46